DSIP (Delta Sleep-Inducing Peptide)
A neuropeptide that promotes slow-wave sleep and has broad regulatory effects on stress hormones and pain.
Community Rating
No ratings yet
Compound Profile
DSIP (Delta Sleep-Inducing Peptide)
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. DSIP (Delta Sleep-Inducing Peptide) is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Promotes deep, slow-wave (delta) sleep
- Reduces cortisol levels — improves stress response
- Analgesic properties — reduces pain perception
- DSIP (Delta Sleep-Inducing Peptide) is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Promotes deep, slow-wave (delta) sleep
- Reduces cortisol levels — improves stress response
- Analgesic properties — reduces pain perception
- Normalizes disturbed sleep patterns
In Plain English
Simple summaryDSIP (Delta Sleep-Inducing Peptide) is a 9-amino acid neuropeptide first isolated from the blood of sleeping rabbits in 1974 by Swiss researchers. The name comes from its original discovery context: when rabbit blood drawn during deep sleep was infused into awake rabbits, it promoted delta-wave sleep. The peptide has an unusual property for a sleep compound -- it's actually amphiphilic, meaning it can cross the blood-brain barrier on its own, which is rare for peptides of any size. Beyond sleep architecture, DSIP has been studied for its effects on stress hormones, particularly its ability to reduce ACTH and cortisol levels, as well as potential applications in opiate and alcohol withdrawal.
- Promotes deep, slow-wave (delta) sleep
- Reduces cortisol levels — improves stress response
- Analgesic properties — reduces pain perception
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is DSIP (Delta Sleep-Inducing Peptide)?
Tap any underlined term for an instant definition.
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood in 1974. As its name suggests, it promotes delta (slow-wave) sleep — the deepest, most restorative stage of sleep. DSIP is widely distributed throughout the brain and peripheral organs and is thought to have a broad regulatory role in neuroendocrine function. Research has shown it to modulate cortisol, somatostatin, and LH levels, while also demonstrating analgesic (pain-reducing), antioxidant, and anti-stress effects. It may also have applications in treating withdrawal symptoms from alcohol and opioids.
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on DSIP (Delta Sleep-Inducing Peptide). See all Cognitive Enhancement peptides for comparison.
Common Stacks
DSIP (Delta Sleep-Inducing Peptide) is frequently combined with the following peptides for synergistic effects. Click any peptide to compare profiles before deciding.
DSIP promotes deep sleep while Ipamorelin maximises the GH pulse that naturally occurs during sleep - synergistic for recovery.
Both influence the pineal gland and circadian rhythm - together they are used for sleep restoration and anti-aging protocols.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Typical research dosing: 100–250 mcg subcutaneously, administered 30–60 minutes before desired sleep. Some protocols use 500 mcg to 1 mg for more pronounced effects. Cycles of 5–7 days followed by breaks are recommended.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Reconstitute with bacteriostatic water. Inject subcutaneously 30–60 minutes before bedtime. Start with lower doses to assess sensitivity. Avoid combining with sedatives or alcohol. Short cycles help prevent receptor desensitization.
What the research doesn't show
The research on DSIP is genuinely old and hasn't been well replicated with modern methodology. Most of the foundational studies are from the 1970s-1990s and used small sample sizes. The blood-brain barrier crossing is real and interesting, but what DSIP actually does inside the brain, and at what doses, remains poorly characterized by current standards.
Research Video
Medical Expert Videos
Physicians, researchers, and pharmacologists explain DSIP (Delta Sleep-Inducing Peptide), covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
DSIP (Delta Sleep-Inducing Peptide) has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: promotes deep, slow-wave (delta) sleep.
The most commonly reported side effect in research subjects is generally well-tolerated. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
How It Compares
Epithalon is another peptide studied for sleep quality, primarily through pineal gland melatonin regulation. DSIP appears to act more directly on sleep architecture. Neither has strong modern clinical trial data. Conventional sleep aids (melatonin, magnesium, sleep hygiene interventions) have a vastly larger evidence base than any research peptide for sleep.
Compare DSIP (Delta Sleep-Inducing Peptide) side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.